PDPK1

3-phosphoinositide dependent protein kinase 1, the group of AGC family kinases

Basic information

Region (hg38): 16:2537979-2603190

Links

ENSG00000140992NCBI:5170OMIM:605213HGNC:8816Uniprot:O15530AlphaFoldGenCCjaxSfariGnomADPubmedClinVar

Phenotypes

GenCC

Source: genCC

No genCC data.

ClinVar

This is a list of variants' phenotypes submitted to ClinVar and linked to the PDPK1 gene.

Variants pathogenicity by type

Statistics on ClinVar variants can assist in determining whether a specific variant type in the PDPK1 gene is commonly pathogenic or not.

In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.

Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.

Variant type Pathogenic Likely pathogenic VUS Likely benign Benign Sum
synonymous
3
clinvar
3
missense
15
clinvar
15
nonsense
0
start loss
0
frameshift
0
inframe indel
0
splice donor/acceptor (+/-2bp)
0
splice region
0
non coding
0
Total 0 0 15 3 0

Variants in PDPK1

This is a list of pathogenic ClinVar variants found in the PDPK1 region.

You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.

Position Type Phenotype Significance ClinVar
16-2538131-C-A not specified Uncertain significance (Dec 15, 2022)2335871
16-2557811-A-G not specified Uncertain significance (Jul 11, 2023)2610354
16-2557829-A-G not specified Uncertain significance (Jul 14, 2021)2387620
16-2557854-G-A not specified Uncertain significance (May 13, 2024)3305595
16-2557865-G-A not specified Uncertain significance (Apr 13, 2022)2378583
16-2557872-T-A not specified Uncertain significance (Aug 14, 2023)2618291
16-2557893-C-T not specified Uncertain significance (Oct 29, 2021)2393043
16-2557895-C-A not specified Uncertain significance (Oct 10, 2023)3211046
16-2561869-G-A not specified Uncertain significance (Aug 10, 2021)2242615
16-2577488-C-T not specified Uncertain significance (Oct 05, 2021)2393773
16-2586755-C-T not specified Uncertain significance (Aug 08, 2022)2277407
16-2586812-C-T not specified Uncertain significance (Sep 20, 2023)3211043
16-2586829-G-C not specified Uncertain significance (Nov 13, 2023)3211045
16-2597124-G-A not specified Uncertain significance (Jun 23, 2023)2605901
16-2597216-C-A not specified Uncertain significance (Aug 09, 2021)2226009
16-2597689-C-T PDPK1-related disorder Likely benign (Jun 18, 2019)3033227
16-2597733-G-A not specified Uncertain significance (Jul 27, 2022)2397100
16-2597749-G-A PDPK1-related disorder Likely benign (Mar 13, 2019)3046933
16-2597752-C-T PDPK1-related disorder Likely benign (Feb 27, 2019)3046732

GnomAD

Source: gnomAD

GeneTypeBio TypeTranscript Coding Exons Length
PDPK1protein_codingprotein_codingENST00000342085 1465225
pLI Probability
LOF Intolerant
pRec Probability
LOF Recessive
Individuals with
no LOFs
Individuals with
Homozygous LOFs
Individuals with
Heterozygous LOFs
Defined p
0.9800.01991257370111257480.0000437
Z-Score Observed Expected Observed/Expected Mutation Rate Total Possible in Transcript
Missense2.01951680.5640.00001003596
Missense in Polyphen932.6650.275521013
Synonymous-0.3007672.71.040.000004991042
Loss of Function3.52116.40.06109.63e-7388

LoF frequencies by population

EthnicitySum of pLOFs p
African & African-American0.000.00
Ashkenazi Jewish0.000.00
East Asian0.000.00
Finnish0.000.00
European (Non-Finnish)0.00009710.0000967
Middle Eastern0.000.00
South Asian0.000.00
Other0.000.00

dbNSFP

Source: dbNSFP

Function
FUNCTION: Serine/threonine kinase which acts as a master kinase, phosphorylating and activating a subgroup of the AGC family of protein kinases. Its targets include: protein kinase B (PKB/AKT1, PKB/AKT2, PKB/AKT3), p70 ribosomal protein S6 kinase (RPS6KB1), p90 ribosomal protein S6 kinase (RPS6KA1, RPS6KA2 and RPS6KA3), cyclic AMP-dependent protein kinase (PRKACA), protein kinase C (PRKCD and PRKCZ), serum and glucocorticoid-inducible kinase (SGK1, SGK2 and SGK3), p21-activated kinase-1 (PAK1), protein kinase PKN (PKN1 and PKN2). Plays a central role in the transduction of signals from insulin by providing the activating phosphorylation to PKB/AKT1, thus propagating the signal to downstream targets controlling cell proliferation and survival, as well as glucose and amino acid uptake and storage. Negatively regulates the TGF-beta-induced signaling by: modulating the association of SMAD3 and SMAD7 with TGF-beta receptor, phosphorylating SMAD2, SMAD3, SMAD4 and SMAD7, preventing the nuclear translocation of SMAD3 and SMAD4 and the translocation of SMAD7 from the nucleus to the cytoplasm in response to TGF-beta. Activates PPARG transcriptional activity and promotes adipocyte differentiation. Activates the NF-kappa-B pathway via phosphorylation of IKKB. The tyrosine phosphorylated form is crucial for the regulation of focal adhesions by angiotensin II. Controls proliferation, survival, and growth of developing pancreatic cells. Participates in the regulation of Ca(2+) entry and Ca(2+)-activated K(+) channels of mast cells. Essential for the motility of vascular endothelial cells (ECs) and is involved in the regulation of their chemotaxis. Plays a critical role in cardiac homeostasis by serving as a dual effector for cell survival and beta-adrenergic response. Plays an important role during thymocyte development by regulating the expression of key nutrient receptors on the surface of pre-T cells and mediating Notch-induced cell growth and proliferative responses. Provides negative feedback inhibition to toll-like receptor-mediated NF- kappa-B activation in macrophages. Isoform 3 is catalytically inactive. {ECO:0000269|PubMed:10226025, ECO:0000269|PubMed:10480933, ECO:0000269|PubMed:10995762, ECO:0000269|PubMed:12167717, ECO:0000269|PubMed:14585963, ECO:0000269|PubMed:14604990, ECO:0000269|PubMed:16207722, ECO:0000269|PubMed:16251192, ECO:0000269|PubMed:17327236, ECO:0000269|PubMed:17371830, ECO:0000269|PubMed:18835241, ECO:0000269|PubMed:9094314, ECO:0000269|PubMed:9445476, ECO:0000269|PubMed:9707564, ECO:0000269|PubMed:9768361}.;
Pathway
PI3K-Akt signaling pathway - Homo sapiens (human);Non-small cell lung cancer - Homo sapiens (human);Focal adhesion - Homo sapiens (human);mTOR signaling pathway - Homo sapiens (human);T cell receptor signaling pathway - Homo sapiens (human);Fc epsilon RI signaling pathway - Homo sapiens (human);Neurotrophin signaling pathway - Homo sapiens (human);Choline metabolism in cancer - Homo sapiens (human);Insulin resistance - Homo sapiens (human);Autophagy - animal - Homo sapiens (human);FoxO signaling pathway - Homo sapiens (human);AMPK signaling pathway - Homo sapiens (human);Thyroid hormone signaling pathway - Homo sapiens (human);Prostate cancer - Homo sapiens (human);Aldosterone-regulated sodium reabsorption - Homo sapiens (human);Toxoplasmosis - Homo sapiens (human);Sphingolipid signaling pathway - Homo sapiens (human);PPAR signaling pathway - Homo sapiens (human);Proteoglycans in cancer - Homo sapiens (human);Hepatitis C - Homo sapiens (human);Apoptosis - Homo sapiens (human);Endometrial cancer - Homo sapiens (human);Insulin signaling pathway - Homo sapiens (human);Intracellular Signalling Through Adenosine Receptor A2b and Adenosine;Intracellular Signalling Through Adenosine Receptor A2a and Adenosine;Insulin Signalling;IGF-Core;MicroRNAs in cardiomyocyte hypertrophy;Angiogenesis overview;Integrin-mediated Cell Adhesion;Human Thyroid Stimulating Hormone (TSH) signaling pathway;Signaling Pathways in Glioblastoma;B Cell Receptor Signaling Pathway;Interleukin-11 Signaling Pathway;Brain-Derived Neurotrophic Factor (BDNF) signaling pathway;Cardiac Hypertrophic Response;Focal Adhesion;VEGFA-VEGFR2 Signaling Pathway;Angiopoietin Like Protein 8 Regulatory Pathway;Focal Adhesion-PI3K-Akt-mTOR-signaling pathway;Leptin Insulin Overlap;PPAR signaling pathway;Endometrial cancer;PI3K-Akt Signaling Pathway;EGF-EGFR Signaling Pathway;Insulin Signaling;T-Cell antigen Receptor (TCR) Signaling Pathway;Serotonin HTR1 Group and FOS Pathway;Signaling by GPCR;Disease;Signal Transduction;Gene expression (Transcription);mtor signaling pathway;role of erk5 in neuronal survival pathway;human cytomegalovirus and map kinase pathways;influence of ras and rho proteins on g1 to s transition;trefoil factors initiate mucosal healing;transcription factor creb and its extracellular signals;regulation of eif-4e and p70s6 kinase;il-2 receptor beta chain in t cell activation;akt signaling pathway;phospholipase c signaling pathway;ras signaling pathway;corticosteroids and cardioprotection;phospholipids as signalling intermediaries;regulation of bad phosphorylation;vegf hypoxia and angiogenesis;b cell survival pathway;VEGFA-VEGFR2 Pathway;nfat and hypertrophy of the heart ;phosphoinositides and their downstream targets;skeletal muscle hypertrophy is regulated via akt-mtor pathway;trka receptor signaling pathway;role of erbb2 in signal transduction and oncology;Generic Transcription Pathway;Downstream TCR signaling;TCR signaling;Activation of AKT2;CD28 dependent PI3K/Akt signaling;CD28 co-stimulation;PI3K Cascade;Costimulation by the CD28 family;IRS-mediated signalling;Insulin receptor signalling cascade;Signaling by Insulin receptor;RNA Polymerase II Transcription;Integrin alphaIIb beta3 signaling;Fc epsilon receptor (FCERI) signaling;IGF signaling;Innate Immune System;Immune System;Ghrelin;Adaptive Immune System;insulin Mam;inactivation of gsk3 by akt causes accumulation of b-catenin in alveolar macrophages;Neuronal System;BCR;actions of nitric oxide in the heart;GPVI-mediated activation cascade;RHO GTPases activate PKNs;Platelet Aggregation (Plug Formation);Platelet activation, signaling and aggregation;IL-7 signaling;RHO GTPase Effectors;Signaling by Rho GTPases;TGF_beta_Receptor;role of nicotinic acetylcholine receptors in the regulation of apoptosis;control of skeletal myogenesis by hdac and calcium/calmodulin-dependent kinase (camk);EGFR1;Integrin signaling;CXCR4-mediated signaling events;ErbB1 downstream signaling;Hemostasis;the igf-1 receptor and longevity;Regulation of TP53 Degradation;Regulation of TP53 Expression and Degradation;BCR signaling pathway;PIP3 activates AKT signaling;JAK STAT pathway and regulation;PDGF;EPO signaling;Regulation of TP53 Activity;Class I PI3K signaling events;Transcriptional Regulation by TP53;Signaling by VEGF;Neurotransmitter receptors and postsynaptic signal transmission;Transmission across Chemical Synapses;RSK activation;CREB phosphorylation through the activation of Ras;Constitutive Signaling by AKT1 E17K in Cancer;PI3K/AKT Signaling in Cancer;Post NMDA receptor activation events;Activation of NMDA receptor and postsynaptic events;IRS-related events triggered by IGF1R;IGF1R signaling cascade;Signaling by Receptor Tyrosine Kinases;VEGF;G beta:gamma signalling through PI3Kgamma;G-protein beta:gamma signalling;GPCR downstream signalling;Intracellular signaling by second messengers;mTOR signaling pathway;Insulin Pathway;Diseases of signal transduction;Signaling events mediated by Hepatocyte Growth Factor Receptor (c-Met);IL8- and CXCR1-mediated signaling events;TCR signaling in naïve CD8+ T cells;CXCR3-mediated signaling events;IGF1 pathway;Signaling events mediated by Stem cell factor receptor (c-Kit);FAS (CD95) signaling pathway;Class I PI3K signaling events mediated by Akt;Trk receptor signaling mediated by PI3K and PLC-gamma;Signaling by Type 1 Insulin-like Growth Factor 1 Receptor (IGF1R);IL8- and CXCR2-mediated signaling events;FGF signaling pathway;Signaling events mediated by VEGFR1 and VEGFR2;TCR signaling in naïve CD4+ T cells;TGF-beta receptor signaling;VEGFR1 specific signals;CD4 T cell receptor signaling-NFkB cascade;Role of LAT2/NTAL/LAB on calcium mobilization;VEGFR2 mediated vascular permeability;insulin;VEGFR2 mediated cell proliferation;CD4 T cell receptor signaling (Consensus)

Recessive Scores

pRec
0.256

Haploinsufficiency Scores

pHI
0.490
hipred
Y
hipred_score
0.748
ghis
0.648

Essentials

essential_gene_CRISPR
N
essential_gene_CRISPR2
E
essential_gene_gene_trap
E
gene_indispensability_pred
E
gene_indispensability_score
0.997

Gene Damage Prediction

AllRecessiveDominant
MendelianMediumMediumMedium
Primary ImmunodeficiencyMediumMediumMedium
CancerMediumMediumMedium

Mouse Genome Informatics

Gene name
Pdpk1
Phenotype
limbs/digits/tail phenotype; nervous system phenotype (the observable morphological and physiological characteristics of the extensive, intricate network of electochemical structures in the body that is comprised of the brain, spinal cord, nerves, ganglia and parts of the receptor organs that are manifested through development and lifespan); vision/eye phenotype; immune system phenotype; renal/urinary system phenotype; skeleton phenotype; embryo phenotype; behavior/neurological phenotype (the observable actions or reactions of mammalian organisms that are manifested through development and lifespan); cardiovascular system phenotype (the observable morphological and physiological characteristics of the mammalian heart, blood vessels, or circulatory system that are manifested through development and lifespan); hematopoietic system phenotype; reproductive system phenotype; normal phenotype; mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); pigmentation phenotype; endocrine/exocrine gland phenotype; neoplasm; adipose tissue phenotype (the observable morphological and physiological characteristics of mammalian fat tissue that are manifested through development and lifespan); muscle phenotype; craniofacial phenotype; homeostasis/metabolism phenotype; cellular phenotype; growth/size/body region phenotype; integument phenotype (the observable morphological and physiological characteristics of the skin and its associated structures, such as the hair, nails, sweat glands, sebaceous glands and other secretory glands that are manifested through development and lifespan);

Gene ontology

Biological process
stimulatory C-type lectin receptor signaling pathway;type B pancreatic cell development;protein phosphorylation;negative regulation of protein kinase activity;hyperosmotic response;epidermal growth factor receptor signaling pathway;positive regulation of phospholipase activity;negative regulation of cardiac muscle cell apoptotic process;cell migration;peptidyl-serine phosphorylation;peptidyl-threonine phosphorylation;calcium-mediated signaling;actin cytoskeleton organization;platelet activation;negative regulation of transforming growth factor beta receptor signaling pathway;T cell costimulation;activation of protein kinase B activity;cellular response to insulin stimulus;negative regulation of toll-like receptor signaling pathway;intracellular signal transduction;Fc-epsilon receptor signaling pathway;regulation of I-kappaB kinase/NF-kappaB signaling;regulation of mast cell degranulation;negative regulation of neuron apoptotic process;positive regulation of blood vessel endothelial cell migration;positive regulation of angiogenesis;protein autophosphorylation;focal adhesion assembly;T cell receptor signaling pathway;positive regulation of release of sequestered calcium ion into cytosol;cellular response to epidermal growth factor stimulus;extrinsic apoptotic signaling pathway;positive regulation of protein localization to plasma membrane;positive regulation of sprouting angiogenesis;positive regulation of vascular endothelial cell proliferation;cellular response to brain-derived neurotrophic factor stimulus;negative regulation of endothelial cell apoptotic process
Cellular component
nucleoplasm;cytoplasm;cytosol;plasma membrane;focal adhesion;postsynaptic density;cytoplasmic vesicle;cell projection;perikaryon
Molecular function
protein serine/threonine kinase activity;3-phosphoinositide-dependent protein kinase activity;insulin receptor binding;protein binding;ATP binding;phospholipase activator activity;kinase activity;protein kinase binding;phospholipase binding